CalciMedica and Telperian team up for Auxora trial analysis

Auxora has been assessed in efficacy trials including the Phase IIb CARPO trial for SIRS and acute pancreatitis.
Pharmabiz

CalciMedica & Telperian collaborate to integrate innovative artificial intelligence engine ...

La Jolla, California Wednesday, October 15, 2025, 13:00 Hrs [IST] ...

CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial ...

CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition ...

CalciMedica, Inc.: CalciMedica and Telperian Announce Collaboration to Integrate Innovative ...

AI tools will allow CalciMedica to analyze Phase 2 datasets to refine the target patient populations and efficacy endpoints for upcoming pivotal trials LA JOLLA ...